HOOKIPA Pharma Inc.
HOOKOTCHealthcare● Active
$1.15
+$0.00(+0.00%)
Market Cap$14395783
P/E Ratio—
52W High$1.65
52W Low$0.811
HOOKIPA Pharma Inc. (HOOK) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HOOK · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2025Report Date: Nov 14, 2025EPS Actual
$0.09
Est. -$0.61 · +114.8%
Revenue
—
Est. $0.00B
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Nov 14, 2025
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
HOOK reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 7, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Aug 7, 2026 | — | — | — | — | — | — |
| ◌ Q1 FY2026 | Mar 30, 2026 | -$0.76 | — | — | — | $0.00B | — |
| ▲ Q4 FY2025 | Nov 14, 2025 | -$0.61 | $0.09 | +114.8% | — | $0.00B | — |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$0.64 | -$1.52 | -137.5% | — | — | — |
| ▼ Q2 FY2025 | May 15, 2025 | -$0.61 | -$1.23 | -101.6% | $0.00B | $0.00B | -40.6% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -$0.41 | -$1.96 | -378.1% | $0.00B | $0.00B | -60.6% |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$1.28 | -$1.10 | +14.1% | $0.00B | $0.01B | -24.8% |
Q3 FY2026
Aug 7, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Aug 7, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 30, 2026
EPS Actual
—
EPS Est.
-$0.76
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 14, 2025Beat
EPS Actual
$0.09
EPS Est.
-$0.61
EPS Surpr.
+114.8%
Revenue
—
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$1.52
EPS Est.
-$0.64
EPS Surpr.
-137.5%
Revenue
—
Q2 FY2025
May 15, 2025Miss
EPS Actual
-$1.23
EPS Est.
-$0.61
EPS Surpr.
-101.6%
Revenue
$0.00B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
-$1.96
EPS Est.
-$0.41
EPS Surpr.
-378.1%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$1.10
EPS Est.
-$1.28
EPS Surpr.
+14.1%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-0.76 | $-0.76 | $-0.76 | 1 |
| Q3 FY2025 | $-0.71 | $-0.71 | $-0.71 | 1 |
| Q2 FY2025 | $-0.61 | $-0.61 | $-0.61 | 1 |
| Q1 FY2025 | $-1.04 | $-1.04 | $-1.04 | 1 |
| Q4 FY2024 | $-1.12 | $-1.12 | $-1.12 | 1 |
| Q3 FY2024 | $-1.28 | $-1.28 | $-1.28 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2025 | Nov 14, 2025 | +114.8% | $0.87 | $0.87 | +0.00% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -137.5% | $0.85 | $0.83 | -2.46% |
| ▼ Q2 FY2025 | May 15, 2025 | -101.6% | $1.41 | $1.45 | +2.84% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -378.1% | $1.51 | $1.50 | -0.66% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +14.1% | $3.42 | $3.14 | -8.19% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -5.6% | $4.91 | $5.06 | +3.05% |
| ▲ Q2 FY2024 | May 9, 2024 | +200.0% | $8.00 | $8.00 | +0.00% |
| ▲ Q1 FY2024 | Mar 22, 2024 | +45.0% | $7.24 | $7.11 | -1.80% |
Q4 FY2025+0.00%
Report Date
Nov 14, 2025
EPS Beat/Miss
+114.8%
Price Before
$0.87
Price After
$0.87
Q3 FY2025-2.46%
Report Date
Aug 14, 2025
EPS Beat/Miss
-137.5%
Price Before
$0.85
Price After
$0.83
Q2 FY2025+2.84%
Report Date
May 15, 2025
EPS Beat/Miss
-101.6%
Price Before
$1.41
Price After
$1.45
Q1 FY2025-0.66%
Report Date
Feb 27, 2025
EPS Beat/Miss
-378.1%
Price Before
$1.51
Price After
$1.50
Q4 FY2024-8.19%
Report Date
Nov 14, 2024
EPS Beat/Miss
+14.1%
Price Before
$3.42
Price After
$3.14
Q3 FY2024+3.05%
Report Date
Aug 8, 2024
EPS Beat/Miss
-5.6%
Price Before
$4.91
Price After
$5.06
Q2 FY2024+0.00%
Report Date
May 9, 2024
EPS Beat/Miss
+200.0%
Price Before
$8.00
Price After
$8.00
Q1 FY2024-1.80%
Report Date
Mar 22, 2024
EPS Beat/Miss
+45.0%
Price Before
$7.24
Price After
$7.11
Avg Beat Reaction-2.50%
Avg Miss Reaction+0.69%
Beat Rate4 / 8 quarters
Largest Move-8.19% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HOOK ends December
HOOKIPA Pharma Inc. (HOOK) most recently reported earnings on November 14, 2025 for Q4 FY2025, posting EPS of $0.09 — beating the analyst consensus of $-0.61 by +114.8%. The next HOOK earnings date is expected around September 1, 2026.
Each quarter, investors track HOOK earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HOOK revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HOOK's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HOOK earnings · 5 questionsHOOKIPA Pharma Inc.'s next earnings report is expected around September 1, 2026. HOOK typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HOOK historically reports after market close (AMC).
HOOK earnings datewhen is HOOK earningsHOOK next earnings datewhen does HOOK report earningsHOOK earnings calendar
▸ Source: FMP · HOOKIPA Pharma Inc. SEC filings · US GAAP · HOOKIPA Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026